CaninKare

Ceftriaxone & Tazobactam For Injection

CEFTRIAXONE

Ceftriaxone & Tazobactam For Injection

Caninkare introduces Cani-TZ, a powerful veterinary injection that combines Ceftriaxone and Tazobactam to treat a wide range of bacterial infections in animals. Designed specifically for veterinary use, this formulation ensures effective and broad-spectrum antibacterial activity, especially in resistant infections.

Key Features:

  • Composition:
    Each vial contains Ceftriaxone 500 mg and Tazobactam 62.25 mg, totaling 562.25 mg per dose.

  • Broad-Spectrum Action:
    Effective against both Gram-positive and Gram-negative bacteria, including strains that produce beta-lactamase enzymes.

  • Enhanced Efficacy:
    Tazobactam works as a beta-lactamase inhibitor, enhancing the effect of Ceftriaxone and preventing antibiotic resistance.

  • Indications:

    • Respiratory tract infections

    • Urinary tract infections

    • Skin and soft tissue infections

    • Post-surgical infections

    • Septicemia and systemic infections

  • Dosage & Administration:

    • For Intramuscular (I.M.) or Intravenous (I.V.) use only

    • Dosage should be as directed by a qualified veterinarian based on the weight and condition of the animal.

  • Safety & Storage:

    • Store in a cool, dry place below 25°C

    • Keep out of reach of children and unauthorized personnel

    • Use under veterinary supervision only

Cani-TZ by Caninkare is trusted by veterinarians for its clinical efficacy, reliability, and ease of administration. It is an ideal choice for treating critical bacterial infections in pets and livestock with proven safety and therapeutic results.